PRWeb Gerber Technology, a world leader in integrated solutions for the apparel and industrial markets, announces the availability of 3D visualization technology as an optional module for AccuMark(R) 10, its industry leading integrated CAD pattern ... RCL Advisors, 1 day ago
Fun activities at each station (D. Aguilera/Fort Worth Theater Examiner) Story time (D. Aguilera/Fort Worth Theater Examiner) Create your own tornado (D. Aguilera/Fort Worth Theater Examiner) Hand puppet area in Munchkin land (D. Aguilera/Fort ...Examiner.com, 32 minutes ago
In the medical community, many vendors use SQL Server. Currently, Asante, a healthcare provider based in southern Oregon, has 68 SQL Servers -- some large for purposes of consolidation and others as small as a single application brought in by a ...SQL Server News, 33 minutes ago
3D Imaging Market Expected To Grow Owing To Widespread Use In Various Industries: Grand View Research, Inc.
Company News: Page (1) of 1 - 05/27/15 print page (May 27, 2015) "Grand View Research, Inc. - Market Research And Consulting." GrandViewResearch.com has announced the addition of "Global 3D Imaging Market Analysis And Segment Forecasts ...Tutorial Finder, 41 minutes ago
Spaniard Alberto Contador took a massive step toward his second Giro dItalia triumph by increasing his overall lead on Fabio Aru after an epic 16th stage, which was won by fellow Spaniard Mikel Landa on Tuesday. Astana rider Landa made up for team ...Taipei Times Online, 50 minutes ago
--- Many countries in the Middle East and North Africa will have to double, triple, or even quadruple their investment in agricultural research and development to meet the targets recommended by the United Nations, according to new research findings ...Food Ingredients First, 51 minutes ago
Corbus Pharmaceuticals : Receives FDA Clearance to Initiate Phase 2 Clinical Study of Resunab for the Treatment of Cystic Fibrosis
By a News Reporter-Staff News Editor at Clinical Trials Week -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (" Corbus " or the "Company"), a clinical stage drug development company targeting rare, life-threatening chronic inflammatory and ...4 Traders, 55 minutes ago
New Study: NuSirt Technology Could Aid in Treatment of Non-Alcoholic Steatohepatitis (NASH) and Type 2 Diabetes
NASHVILLE, Tenn. -- (BUSINESS WIRE) -- NuSirt Biopharma today announced publication of new research showing that its technology combining leucine, an amino acid, with very low doses of phosphodiesterase 5 (PDE5) inhibitors has the potential to ...Freshnews.com, 55 minutes ago
A covered call identified by MarketIntelligececenter.com's patented algorithm on Fiserv Inc ( FISV ) could yield about 2.66% (4.73% annualized, for comparison purposes only) in 205 days. Pair a long position in the stock with the Dec. '15 $75.00 ...TradingCharts.com, 57 minutes ago Potential Northern Trust (NTRS) Trade Targets 2.40% Return TradingCharts.com, 2 hours ago Potential Vanguard S&P 500 ETF (VOO) Trade Has 2.80% Downside Protection TradingCharts.com, 2 hours ago Potential Microchip Technology (MCHP) Trade Targets 2.49% Return TradingCharts.com, 5 hours ago
More from: , PredictWallStreet...and 1 other sources
Innocrin Pharmaceuticals, Inc. Initiates Phase 2 Castration-Resistant Prostate Cancer (CRPC) Study in Men Who Have Failed Enzalutmaide or Abiraterone
Innovative Correlative Study to Assess VT-464 Benefit in CRPC Patients Refractory to Abiraterone or Enzalutamide RESEARCH TRIANGLE PARK, N.C.(BUSINESS WIRE) Innocrin Pharmaceuticals, Inc., a clinical-stage pharmaceutical company ...Pharmacy Choice, 59 minutes ago
on your WebpageAdd Widget >Get your members hooked!